Welcome to Blacktown Business Access

RESEARCH from UNSW’s Centre for Healthy Brain Ageing (CHeBA) highlights hypertension treatment as a key Alzheimer’s prevention strategy. A study of 31,250 individuals found untreated hypertension after age 60 increases Alzheimer’s risk by 42%, while treated hypertension eliminates this risk. Antihypertensive benefits persist into the 80s, with similar effects across genders and ethnicities. Experts urge global efforts to address hypertension, crucial in tackling the growing dementia crisis.